Published on September 11, 2008
APOLLO
MEDICAL HOLDINGS APPOINTS NOEL DEWINTER CHIEF FINANCIAL
OFFICER
Glendale,
California, September 11, 2008 – Apollo Medical Holdings, Inc.
(OTC-BB:AMEH), a leading provider of management services to medical groups
that
provide comprehensive hospital-based medical services, today announced the
appointment of A. Noel DeWinter as Apollo’s Chief Financial
Officer.
Mr.
DeWinter brings over 30 years of finance, management and transactional
experience to the Apollo team, including 10 years at Wahlco Environmental
Systems, Inc. (NYSE: WES), which he joined in 1990 as chief financial officer
and vice president. He was instrumental in Wahlco’s 1990 initial public offering
on the New York Stock Exchange. Prior to joining Apollo, Mr. DeWinter most
recently served as chief financial officer of Bridgetech Holdings International,
Inc., a company focused primarily on the business of facilitating the transfer
of medical drugs, devices and diagnostics from the United States to China
and
other international locations. He has also served as CFO of Capital Pacific
Homes, Inc., a Newport Beach-based diversified residential and commercial
real
estate development company and Vilink Communications, Inc., a manufacturer
of
fiber-optic communications equipment. He also served in numerous financial
positions with Global Marine, Inc., a NYSE offshore oil drilling and exploration
company for 8 years and later as vice president of Houston-based Challenger
Minerals, Inc, an oil and gas exploration company.
Mr.
DeWinter holds a BA in Economics from Carleton College and an MBA from the
Wharton School at the University of Pennsylvania.
“Noel
has
tremendous experience in the financial and operational realms, which will
be
invaluable to us as we build a robust business with long-term prospects.,”
stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical
Holdings, Inc.
“I
am
excited to join a pioneering company in a truly dynamic, new sector of the
healthcare market,” stated DeWinter. “I think Apollo has tremendous potential. I
look forward to working with the rest of the management team as we implement
Apollo’s financial and operational strategies.”
About
Apollo Medical Holdings, Inc.
Apollo
is
a leading provider of management services to medical groups that provide
comprehensive hospital-based medical services. The company intends to capitalize
on the growing market for hospital-based physicians, such as hospitalists,
or
physicians with expertise in hospital medicine. There are 4900 acute care
hospitals in the U.S., with over 35 million annual admissions. Total U.S.
spending on hospital care is over $650 billion, and is expected to increase
to
$1.3 trillion by 2016. There are tremendous inefficiencies in the delivery
of
inpatient care and a high rate of hospital errors. Both of these are drivers
for
the growth of hospital-based medicine. Apollo and its affiliated medical
groups
have proven expertise in providing excellent and efficient care to hospitalized
patients.
Safe
Harbor Statement
Under
the
Private Securities Litigation Reform Act of 1995: Except for historical
information contained herein, the statements in this news release are
forward-looking statements that are made pursuant to the safe harbor provisions
of the Private Securities Act of 1995. Forward-looking statements involve
known
and unknown risks and uncertainties, which may cause a company’s actual results,
performance and achievement in the future to differ materially from forecasted
results, performance and achievement. These risks and uncertainties are
described in the Company’s periodic filings with the Securities and Exchange
Commission. The Company undertakes no obligation to publicly release the
results
of any revisions to these forward-looking statements that may be made to
reflect
events or circumstances after the date hereof, or to reflect the occurrence
of
unanticipated events or changes in the Company’s plans or
expectation.